ML20216J117

From kanterella
Jump to navigation Jump to search
Staff Requirements Memo Re SECY-97-177 Concerning Final Rulemaking Plan:Rev of Dose Limit for Members of Public Exposed to Hospitalized Patients.Commission Has No Objection to Proposed Rulemaking Plan
ML20216J117
Person / Time
Issue date: 09/09/1997
From: Hoyle J
NRC OFFICE OF THE SECRETARY (SECY)
To: Callan L
NRC (Affiliation Not Assigned)
References
REF-10CFR9.7 SECY-97-177-C, NUDOCS 9709170163
Download: ML20216J117 (2)


Text

_

UNITED STATES l

RELEASEDTO THE PDR k-

  • ^

NUCLEAR REGULATORY COMMISSION, WASHINGTON, D C. 20555-C001

)cg C

date initi

  • * * * * * * * * * * * * * ' * * *a ls -

'+o.....

September 9 1997 OFFICE OF THE SECRETARY

-MEMORANDUM TO:

L. Joseph Callan Executiv Director for Operations FROM:

John C. Hoyle % p n % \\ln m 4 & {Lg

SUBJECT:

STAFF REQUIREMENTS - SECY-97-177 - FINAL RULEMAKING PLAN:

REVISION OF DOSE LIMIT FOR MEMBERS OF THE ?UBLIC EXPOSED TO HOSP""JsIZED PATIENTS (10 CFR PART 20 AND 35)

This is to advise you that the Commission has not objected to the staff's proposed rulemaking plan as described in Option 3 subject to the following comments.

The staff should justify on a public health and safety benefit basis the requirement for licensee documentation that it has provided instruction t.o the f amily members and that it has obtained informed consent from the family members in light of the fact that documentation of instruction to and informed consent from, released patients is not required under 10 CFR 35.75(a) or (b).

If retained, this recordkeeping issue should-be specifically discussed in the Federal Reaister notice accompanying the proposed. rule and the staff should seek public comments and views on the need for these recordkeeping requirements.

Should the consent form eventually'be used, the staff should coordinate with ACMUI to draft a " plain English" informed consent form.

Any public notice of this rule should make it clear that family.

members admitted to the room of a patient treated with prmanent implants, or administered radiopharmaceutical therapy, al subsequently released under 10 CFR 35.75 may, as a result of this J

rulemaking, actually receive a total dose of 1.0 rem.

I The new compatibility categories' described in the " Policy for-

-Adequacy and Compatibility of Agreement State Programs" should be reflected in this rulemaking plan.

O O ' & [> b/

k SECY-NOTE:

THIS SRM AND SECY-97-177 WILL BE MADE PUBLICLY AVAILABLE 5 WORKING DAYS FROM THE DATE OF THIS SRM.

'\\ 6 W*I882"""

ll1111111111011R111111111 PT9.7 PDR l

... cc:

Chairman Jackson Commissioner Dicus Commissioner Diaz Commissioner McGaffigan OGC CIO

.CFO OCA OIG Office Directors, Regions, ACRS, ACNW, ASLBP (via E-Mail)

PDR DCS l

l 1

I r/

. _.